Safety of hyperbaric oxygen therapy in... (2017 study) Skip to main content
Prospective Study International maritime health 2017

Safety of hyperbaric oxygen therapy in mechanically ventilated patients.

Bessereau J, Aboab J, Hullin T, Huon-Bessereau A, Bourgeois JL, Brun PM, et al., International maritime health, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

French researchers followed 150 patients who needed a breathing machine during hyperbaric oxygen therapy over 6 years at one university hyperbaric centre and recorded how the sessions went.

What They Found

This prospective study of 150 mechanically ventilated patients (11 children and 139 adults) treated with hyperbaric oxygen therapy found that carbon monoxide poisoning (51%) and iatrogenic gas embolism (33%) were the two main reasons for intubation, and that the most common side effect, patient-ventilator asynchrony, occurred in 6 patients (5%). Midazolam with sufentanil was the most used sedation, given to 85 patients (67%). All patients received a bolus of a neuromuscular blocker during the session, including the 35 patients who had acute respiratory distress syndrome (ARDS). Mortality was higher in the ARDS group, at 23%.

What This Means for Canadian Patients

For people with carbon monoxide poisoning or gas embolism who are already on a ventilator, this study describes who received hyperbaric oxygen therapy in this setting and which side effects were seen. The authors concluded that mechanical ventilation was safe during these sessions in their study, and that sedation needs to be improved to avoid patient-ventilator asynchrony. The abstract also reports higher mortality in patients with ARDS, so these patients were a high-risk group.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study took place at a single French centre, had no comparison group of patients who were not ventilated, and mainly described side effects and outcomes, so it cannot show that the ARDS group's higher mortality was caused by anything related to the therapy itself.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 28357836
Year Published 2017
Journal International maritime health
MeSH Terms Adult; Carbon Monoxide Poisoning; Chest Tubes; Child; Embolism, Air; Female; France; Humans; Hyperbaric Oxygenation; Hypnotics and Sedatives; Iatrogenic Disease; Male; Respiration, Artificial; Respiratory Distress Syndrome; Vasoconstrictor Agents

Cite This Study

Share

This study relates to Carbon Monoxide Poisoning. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology